Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure

Table 4 Clinical characteristics of patients receiving corticosteroid treatment

Case	Treatment	Loading dose of corticosteroid (mg/d)	Duration (d)1	MELD2	Hepatic encephalopathy2	Creatinine (mg/dL)2	Adverse events	Outcome
1	mPSL	30	16	23	None	0.77	None	Survival
7	PSL	50	26	24	None	0.93	Oral fungal infection	Survival
18	mPSL	32	35	19	None	0.75	Oral fungal infection	Survival
20	mPSL	32	21	20	None	0.76	Oral fungal infection, pulmonary fungal infection	Survival
12	mPSL	24	105	25	None	0.86	Oral fungal infection, pulmonary fungal infection	Death
16	mPSL	24	101	26	None	0.58	Oral fungal infection	Death
19	PSL	30	67	36	Yes	1.41	Oral fungal infection	Death

¹Days from diagnosis to corticosteroid therapy;

²At corticosteroid application. PSL: Prednisolone; mPSL: Methylprednisolone.